A major breakthrough in neuroscience was the discovery that astrocytes interact intimately with neurons to support and regulate essential functions and thereby foster information processing in the brain [1] [2] [3] [4] [5] [6] [7] [8] . Many investigations have focused on astroglia-neuron interactions at tripartite synapses, where astrocyte processes wrap tightly around presynaptic and postsynaptic sites 9 . By contrast, less attention has been placed on astroglia-neuron interactions in proximity to the neuronal soma. In particular, how astrocytes regulate the intrinsic firing patterns of neurons, and what structural basis may underlie this regulation, have been much less explored.
A major breakthrough in neuroscience was the discovery that astrocytes interact intimately with neurons to support and regulate essential functions and thereby foster information processing in the brain [1] [2] [3] [4] [5] [6] [7] [8] . Many investigations have focused on astroglia-neuron interactions at tripartite synapses, where astrocyte processes wrap tightly around presynaptic and postsynaptic sites 9 . By contrast, less attention has been placed on astroglia-neuron interactions in proximity to the neuronal soma. In particular, how astrocytes regulate the intrinsic firing patterns of neurons, and what structural basis may underlie this regulation, have been much less explored.
Despite the surging interest in the role of the LHb in depression [10] [11] [12] [13] [14] [15] [16] [17] [18] , only limited attention has been given to the influence of astrocyte malfunction in the LHb on the aetiology of depression 19 . In an accompanying paper, we show that the bursting activity of LHb neurons is greatly enhanced in animal models of depression 20 . LHb bursting drives depressive-like behaviours and is a prominent target of the rapid antidepressant ketamine 20 . However, the cause of this enhanced bursting by LHb neurons remains unknown.
LHb Kir4.1 is upregulated in depression
We used an unbiased, high-throughput, quantitative proteomic screen to compare habenular protein expression between congenitally learned helpless (cLH) 21 and wild-type Sprague-Dawley rats. Kir4.1 was highly upregulated in the habenulae of cLH rats 14 (1.69-fold of wild-type, Extended Data Fig. 1a ). Western blot analysis confirmed that Kir4.1 was significantly increased (1.44-fold, P = 0.009) in the membrane protein fraction of habenulae from cLH rats (Fig. 1a) . By contrast, another astrocyte-specific protein, glial fibrillary acidic protein (GFAP), showed no change in expression (Extended Data Fig. 1b ), indicating that there was no astrogliosis.
To test whether Kir4.1 upregulation is universal in depression, we examined rats in which depression was induced by treatment with lipopolysaccharide (LPS) 22 . One week of LPS injection (0.5 mg kg −1 per day, intraperitoneal (i.p.)) was sufficient to cause strong depressivelike phenotype in three-month-old Wistar rats in the forced swim test (FST; Extended Data Fig. 1c ) 22 and sucrose preference test (SPT) 22 .
Rats with LPS-induced depression also showed a significant increase in Kir4.1 in the habenula (1.87-fold, P < 0.0001, Fig. 1b ). Quantitative real-time PCR revealed an increase (1.2-fold) in Kir4.1 (also known as Kcnj10) mRNA level in habenulae from cLH rats (Extended Data Fig. 1d ), suggesting that at least part of the change in protein level is due to transcriptional upregulation. Kir4.1 is a principal component of the glial Kir channel and is largely responsible for mediating the K + conductance and setting the 1 protein in membrane fraction of habenulae of cLH rats (n = 9, 9 rats for WT and cLH, respectively, a) and rats with LPS-induced depression (n = 6, 6, b). Tubulin is used as loading control. WT, wild-type Sprague-Dawley rats. c, d, I-V plot and bar graph showing Ba 2+ -sensitive currents in cLH rats and wild-type controls at the age of P60-90 (c) and P30 (d). e, f, Agedependent FST (e) and LHT (f) phenotypes of cLH rats. n = 8, 8 rats for P30, n = 10, 10; 6, 6 rats for P90 FST and LHT, respectively. Data are means ± s.e.m. * P < 0.05, * * P < 0.01, * * * * P < 0.0001; NS, not significant. Two-tailed paired t-test (a, b), two-tailed unpaired t-test (c, e, f) and Mann-Whitney test (d).
Article reSeArcH resting membrane potential (RMP) in astrocytes [23] [24] [25] . To confirm that Kir4.1 function is indeed upregulated in rat models of depression, we performed whole-cell patch-clamp recordings onto LHb astrocytes from cLH or wild-type rats. Astrocytes were distinguished from neurons by their small (5-10 μ m), oval somata and electrophysiological features (Extended Data Fig. 2a-d ; see Methods). Biocytin filling and the absence of NeuN co-staining confirmed that cells fitting the above criteria were indeed astrocytes (Extended Data Fig. 3 ). We then bath-applied Ba 2+ (BaCl 2 , 100 μ M), which selectively blocks Kir channels at sub-millimolar concentrations, to isolate Kir4.1 current 24 (Extended Data Fig. 2a, c) . The Ba 2+ -sensitive current displayed a reversal potential close to the equilibrium potential of K + (E K ) (− 90 mV) 23, 24 (Fig. 1c, d ), indicating that it represents the K + conductance. We found that Ba 2+ -sensitive currents in LHb astrocytes were almost doubled in astrocytes from cLH ( Fig. 1c) and LPS-treated rats (Extended Data Fig. 2f ) at postnatal days (P)60-90.
Notably, the increase in Kir4.1 current and protein level was not obvious in cLH rats at P30 (Fig. 1d, Extended Data Fig. 1e ). At this age, cLH rats did not yet show depression-like phenotypes in either the FST (Fig. 1e) or the learned helplessness test (LHT; Fig. 1f) , suggesting that the upregulation of Kir4.1 is concomitant with the developmental onset of the depression-like symptoms.
Kir4.1 on astrocytes encircles neuronal soma
As an inwardly rectifying K + channel, Kir4.1 has been strongly implicated in buffering excess extracellular K + in tripartite synapses [25] [26] [27] [28] . The conventional model of K + buffering suggests that Kir4.1 is highly expressed in astrocytic endfeet surrounding synapses 29, 30 . Unexpectedly, immunohistochemical staining for Kir4.1 in the LHb appeared to overlap with the neuronal marker NeuN at low magnification (20× ; Extended Data Fig. 4a ), although in the same brain slice Kir4.1 staining in the hippocampus showed a typical astrocytic appearance (Extended Data Fig. 4b ). However, higher magnification imaging with single-layer scanning (0.76 μ m per layer) revealed that Kir4.1 staining enveloped NeuN signals (Fig. 2a) . To confirm that Kir4.1 was located within astrocytes but not neurons in the LHb, we separately knocked it out in either neurons or astrocytes by injecting AAV viruses expressing the Cre recombinase under either the neuronal Camk2a promoter or the glial GFAP promoter (gfaABC1D) 7, 31 into Kir4.1 floxed (Kcnj10 f/f ) mice 24 . Neuronal knockout of Kir4.1 expression did not change the pattern of Kir4.1 staining, but astrocytic knockout completely eliminated it (Fig. 2b) . Electron microscopy imaging revealed that Kir4.1-positive gold particles encircled the membrane of neuronal cell bodies (Fig. 2c, Extended Data Fig. 5a , b) as well as synapses (Extended Data Fig. 5c ). Consistently, whole-cell patch-clamp recordings showed that Ba 2+ -sensitive currents were absent from neurons but abundant in astrocytes in the LHb (Fig. 2d, Extended  Data Fig. 6 ). Together these results suggest that Kir4.1 is mainly expressed in astrocytic processes that wrap tightly around neuronal somata and synapses in the LHb.
Kir4.1 gain-of-function causes depression
To test the consequences of Kir4.1 upregulation in the LHb, we used adeno-associated viruses of the 2/5 serotype (AAV2/5), which preferentially target astrocytes 7 , together with the human GFAP (gfaABC1D) promoter 7, 31 to deliver eGFP-tagged Kir4.1 channel (AAV-GFAP::Kir4.1) or eGFP alone (AAV-GFAP::eGFP) as a control (Fig. 3a) . Twenty-one days after bilateral injection into the LHb at P50, AAV2/5-mediated viral transfection led to expression of Kir4.1 and eGFP in astrocytes throughout the LHb (Fig. 3a) . The specificity of the viral infection in astrocytes was verified by co-immunostaining of NeuN and eGFP: only 0.3% of NeuN + cells (n = 2,668) were infected by this virus (Extended Data Fig. 7a ). We made whole-cell patch-clamp recordings from either astrocytes or neurons surrounding the virally transfected astrocytes in coronal LHb slices (Fig. 3b-e) . The RMPs of Data are means ± s.e.m. * P < 0.05, * * P < 0.01, * * * P < 0.001, * * * * P < 0.0001.
Two-tailed unpaired t-test (c, d, f, g) and χ 2 test (e).
Article reSeArcH both astrocytes and neurons were more hyperpolarized ( Fig. 3c, d ) and the percentage of bursting neurons was significantly higher ( Fig. 3e , P < 0.0001) in mice infected with AAV-GFAP::Kir4.1 than in mice infected with AAV-GFAP::eGFP. We then assayed depression-like phenotypes and found that mice with AAV-GFAP::Kir4.1 infection in the LHb displayed severe depressionlike behaviours, including increased immobile duration and decreased latency to immobility in the FST (Fig. 3f) , and decreased sucrose preference in the SPT (Fig. 3g ), while general locomotion was unchanged (Extended Data Fig. 7c, d ).
Kir4.1 regulates neuronal RMP and bursting
How does an astrocytic K + channel regulate the RMP and burst firing of LHb neurons? We hypothesize that within the highly confined extracellular space between neuronal somata and Kir4.1-positive astrocytic processes (Fig. 2) , the constantly released K + from intrinsically active LHb neurons is quickly cleared by astrocytes through a Kir4.1-dependent mechanism. Accordingly, we predict that blockade of Kir4. Fig. 4f ). This led to a reduction in neuronal RMP of 13.7 ± 0.5 mV (Fig. 4g ) and a direct shift of originally tonic-firing neurons (8 out of 15) into bursting mode. Consequently, the percentage of bursting neurons was increased from 8% to 23% (Fig. 4h) . Thus, by increasing astrocytic Kir4.1 expression or decreasing extracellular K + concentration, we were able to phenocopy in wild-type animals several key neuronal properties observed in the LHb of animal models of depression, namely hyperpolarized RMPs and enhanced bursts. These results indicate that enhanced extracellular K + clearance resulting from overexpression of Kir4.1 might underlie the neuronal hyperpolarization required for burst initiation.
Kir4.1 loss-of-function rescues depression
To determine whether loss-of-function of Kir4.1 in the LHb could reduce neuronal bursts and reverse depressive phenotypes, we devised two strategies. We used AAV2/5 viral vectors to express either a short hairpin RNA (shRNA) to knock down the level of Kir4.1, or a dominantnegative construct to block its function, in the LHb of cLH rats (Fig. 5a) . We tested six shRNAs that specifically targeted the Kir4.1 transcript in cell culture and chose the one with highest knockdown efficiency ( Fig. 5b and Extended Data Fig. 10a ) for viral packaging. To avoid an off-target effect of the shRNA, we also used a dominant-negative form of Kir4.1 (dnKir4.1), which contains a GYG-to-AAA point mutation at the channel pore, which blocks K + channels 32 ( Fig. 5a , c, Extended Data Figs 7b, 10b). We first examined the effect of Kir4.1-shRNA on glial and neural electrophysiological properties. In astrocytes infected with AAV-H1::Kir4.1-shRNA, we observed a marked change in the current-voltage (I-V) relationship (Fig. 5d ) and a depolarization of 41 mV compared with astrocytes infected with control shRNA (Fig. 5e) , consistent with previous findings that Kir4.1 is mainly responsible for 2 (100 μ M, n = 7, 11, 12 neurons from 3, 3, 3 rats for silent, bursting and tonic, respectively, a) or TTX (1 μ M, n = 13, 9, 9 neurons from 2, 2, 2 rats, d) in different neuronal types. RMPs were measured 15 min or 5 min after perfusion with BaCl 2 or TTX, respectively, when the RMPs had stabilized. b, e, Changes in neuronal RMPs after BaCl 2 (n = 14, 9 neurons from 3, 3 rats for tonic and burst group, respectively, b) or TTX (n = 9, 9 neurons from 2, 2 rats, e) treatment correlate with original firing rates of tonic-firing neurons (blue) or intra-burst frequencies of bursting neurons (red). c, Representative trace (left) and bar graph (right, 9 neurons from 3 rats) showing effect of BaCl 2 (15 min after drug perfusion) on bursting neurons. Spikes in bursting and tonic firing modes are shown in blue and black, respectively. f, Example of LHb neurons transforming from tonicfiring to burst-firing mode after [K] out is reduced from normal (2.75 mM) by 50% (to 1.4 mM). g, h, Reducing [K] out by 50% decreases neuronal RMPs (n = 15 neurons from 4 rats, sampled 1 min after change in [K] out , g) and increases bursting neural population (n = 33, 40 neurons from 4, 6 rats for normal and reduced [K] out , respectively, h). Data are means ± s.e.m. * P < 0.05, * * P < 0.01, * * * P < 0.001, * * * * P < 0.0001. Two-tailed paired t-test (a, c, d, g), χ
2 test (h) and linear regression test (b, e). . The RMPs of neurons infected with AAV-H1::Kir4.1-shRNA did not differ from those of neighbouring noninfected neurons (because neurons do not express Kir4.1 endogenously, Fig. 5f ). However, the RMPs of neighbouring LHb neurons in AAV-H1::Kir4.1-shRNA-infected brain slices were overall more depolarized than the RMPs of neurons from rats infected with the control shRNA ( Fig. 5f ), suggesting that knock-down of Kir4.1 in astrocytes had a widespread impact on the RMPs of neighbouring neurons. Similar effects were observed in LHb slices infected with AAV-GFAP::dnKir4.1 (Extended Data Fig. 10c-f) . Notably, bursting activity in the LHb of cLH rats was eliminated by infection with AAV-H1::Kir4.1-shRNA (Fig. 5g) or AAV-GFAP::dnKir4.1 (Extended Data Fig. 10f) .
Behaviourally, infection with AAV-H1::Kir4.1-shRNA or AAV-GFAP::dnKir4.1 caused a pronounced reduction in the depression-like phenotypes of cLH rats in three depression paradigms: it reduced immobility in the FST (Fig. 5h) , increased bar pressing number in the LHT (Fig. 5i, j) , and increased sucrose preference in the SPT (Fig. 5k) . The behaviour scores in the LHT correlated with those in the FST (Fig. 5l) .
Concluding remarks
Here we describe an important function of Kir4.1 in regulating neuronal RMP and firing pattern at the highly specialized neuronglia interface in the LHb. During depression, upregulation of Kir4.1 may cause enhanced extracellular K + clearance, leading to a decrease in [K] out and neuronal hyperpolarization (Fig. 5m) . As demonstrated in the accompanying publication 20 , neuronal hyperpolarization may de-inactivate T-type voltage-sensitive calcium channels (T-VSCCs), which in turn initiate NMDAR-dependent bursts and thereby increase suppression of downstream monoaminergic centres (Fig. 5m) . These results may inspire the development of new treatments for major depression targeting maladaptive neuron-glia interactions in the LHb. Lever press (#) . j, Percentage of rats in each category. LH, learned helpless rats with < 5 lever presses; NLH, non-learned helpless rats with > 10 lever presses. l, FST immobility is highly correlated with learned helplessness phenotype. m, A model for mechanisms of depression and ketamine treatment in the LHb. Upregulation of Kir4.1 on astrocytic processes surrounding neuronal somata leads to enhanced K + buffering at the tight neuron-glia junction, decreased [K] out and hyperpolarized neuronal RMP. Consequently, de-inactivation of T-VSCCs initiates NMDAR-dependent bursts, causing a stronger output of LHb to trigger depression. Ketamine blockade of NMDARs stops bursting and relieves depression. Data are means ± s.e.m. * P < 0.05, * * P < 0.01, * * * P < 0.001, * * * * P < 0.0001, NS, not significant. (See Supplementary Table 1 for statistical analysis and n numbers.)
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Animals.
Male cLH rats (3-4 weeks or 8-12 weeks of age) and age-matched male Sprague Dawley rats (SLAC Laboratory Animal Co.) were used. The cLH rats were screened using the learned helpless test 14, 21 for breeding as previously described 21 . Male Wistar rats (SLAC Laboratory Animal Co, 12 weeks) were used for establishing the LPS-induced depressive-like rat model. Male adult (7-8 weeks of age) C57BL/6 mice (SLAC) were used for virus injection in the behaviour experiments. Kir4.1 floxed (Kcnj10 f/f ) mice (originally obtained from K. McCarthy at University of North Carolina) were used for virus injection in the immunohistochemistry experiments. Animals were group-housed two per cage for rats and four per cage for mice under a 12-h light-dark cycle (light on from 7a.m. to 7p.m.) with access to food and water ad libitum. All animal studies and experimental procedures were approved by the Animal Care and Use Committee of the animal facility at Zhejiang University. Western blotting. The habenular membrane fraction and whole proteins were extracted as previously described 14 . Animals were anaesthetized using isoflurane, and habenular tissue was quickly dissected from the brain and homogenized in lysis buffer (320 mM sucrose, 4 mM HEPES pH 7.4, 1 mM MgCl 2 and 0.5 mM CaCl 2 , 5 mM NaF, 1 mM Na 3 VO 4 , EDTA-free, protease inhibitor cocktail tablets (Roche) on ice. The lysis buffer used for extracting the total protein of HEK293TN cells contained 50 mM Tris (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS and protease inhibitor cocktail tablets (Roche). After protein concentration measurement by BCA assay, 10-20 μ g protein for each lane was separated on a 10% SDS-PAGE gel and transferred for western blot analysis. Rabbit anti-Kir4.1 intracellular peptide (1:1,000, Alomone labs), mouse anti-GFAP (1:1,000, Sigma), mouse anti-α -tubulin (1:5,000, Sigma) and mouse anti-GAPDH-HRP (1:5,000, KangChen Bio-tech Inc.) antibodies, and high-sensitivity ECL reagent (GE Healthcare) were used. All the bands were analysed with Quantity One or Image J. Immunohistochemistry. Animals were anaesthetized using 10% chloral hydrate, and then perfused transcardially with ice-cold PBS (pH 7.4) followed by 4% paraformaldehyde. After overnight post fix in 4% paraformaldehyde solution, brains were cryoprotected in 30% sucrose for 1 day (for mice) or 3 days (for rats). Coronal sections (40 μ m) were cut on a microtome (Leica) and collected in PBS and stored at 4 °C for further use. The antibodies used were rabbit anti-Kir4.1 extracellular peptide (1:200, Alomone labs), mouse anti-GFAP (1:500, Sigma), mouse antiNeuN (1:500, Millipore), rabbit anti-NeuN (1:500, Millipore), mouse anti-S100B (1:500, Sigma), chicken anti-GFP (1:1,000, Abcam), mouse anti-Flag (1:1,000, Beyotime), Alexa Fluor 488 goat anti-rabbit IgG, Alexa Fluor 488 goat anti-chicken IgG, Alexa Fluor 546 goat anti-mouse IgG (all 1:1,000, Invitrogen). Specifically, for Kir4.1 staining, the rabbit anti-Kir4.1 extracellular peptide antibody was incubated for 48-72 h and the other primary antibodies were incubated for 36-48 h. For the antibody absorption experiments, the rabbit anti-Kir4.1 extracellular peptide antibody was pre-adsorbed with the Kir4.1 extracellular antigen by mixing at a weight ratio of 1:2 for 24 h. Slices for checking the injection site were counterstained with Hoechst in the final incubation step. Fluorescent image acquisition was performed with an Olympus Fluoview FV1000 confocal microscope and a Nikon A1 confocal microscope. Cell transfection and cell culture. Human embryonic kidney (HEK293) cells (gift from J. Luo) were used for the electrophysiology recording and HEK293TN cells (Taitool Bioscience) were used for western blot analysis. Cells used in this study were authenticated and checked for mycoplasma contamination. The plasmids used were pAAV-Ubi-Kir4.1-2A-eGFP, pAAV-Ubi-dnKir4.1 (GYG to AAA)-2A-eGFP, pAAV-CAG-eGFP, pAAV-H1-Kir4.1-shRNA-CAG-eGFP and pAAV-H1-Luciferase-shRNA-CAG-eGFP. HEK293 or HEK293 TN cells were grown in DMEM (HyClone) with 10% FBS (HyClone) at 37 °C and 5% CO 2 . Cells were transfected with appropriate constructs 24 h after plating using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Culture medium was replaced 5-6 h after transfection. Cells were cultured for another 48 h before western blotting or electrophysiology experiments. Plasmid constructs. The pAAV-Ubi-Kir4.1-2A-eGFP plasmid was assembled by homologous recombination of an AAV backbone linearized from the AAV-Ubi-CaMKII-2A-eGFP plasmid 14 by PCR and Kir4.1 amplified from a pZac2.1-gfaABC1D-eGFP-Kir4.1 plasmid (AddGene). The pAAV-Ubi-dnKir4.1 (GYG to AAA)-2A-eGFP plasmid was made by PCR-based mutagenesis using pAAV-Ubi-Kir4.1-2A-eGFP as a backbone (fw: 5′ -ACCATTGCCGCCGCC TTCCGCTACATCAGCGA-3′ ; rev: 5′ -GGCGGCGGCAATGGTGGTCTGG GATTCGAGGGA-3′ ). The pAAV-gfaABC1D-dnKir4.1(GYG to AAA)-2A-eGFP plasmid was assembled by homologous recombination of a pZac2.1-gfaABC1D backbone linearized from the pZac2.1-gfaABC1D-eGFP-Kir4.1 plasmid (AddGene) by PCR and a Kir4.1dn-2A-eGFP sequence amplified from the pAAVUbi-dnKir4.1(GYG to AAA)-2A-eGFP plasmid. The pAAV-H1-Kir4.1-shRNA-CAG-eGFP plasmid was constructed using a vector (Taitool Bioscience), which contains a CAG promoter driving eGFP and an H1 promoter driving shRNA expression. We designed six shRNA sequences using RNAi designer online software (http://rnaidesigner.thermofisher.com/rnaiexpress/; Invitrogen) as indicated below: 1) 5′ -GGACGACCTTCATTGACAT-3′ 2) 5′ -GCTACAAGCTTCTGCTCTTCT-3′ 3) 5′ -GCTCTTCTCGCCAACCTTTAC-3′ 4) 5′ -CCGGAACCTTCCTTGCAAA-3′ 5) 5′ -GCGTAAGAGTCTCCTCATTGG-3′ 6) 5′ -GCCCTTAGTGTGCGCATTA-3′
We then tested the knockdown efficiency by western blot of Kir4.1 from HEK293TN cells which were co-transfected with Flag-tagged-Kir4.1 plasmid (pAAV-CMV-betaGlobin-Kir4.1-eGFP-3Flag) and each of the six shRNA plasmids. Based on our western blot result (Extended Data Fig. 10a) , we chose the fifth sequence, 5′ -GCGTAAGAGTCTCCTCATTGG-3′ , for the Kir4.1-shRNA virus package. Electron microscopic immunohistochemistry. Four mice were deeply anaesthetized with 1% sodium pentobarbital intraperitoneally (50 mg/kg body weight) and perfused transcardially with 20 ml saline, followed by 40 ml ice-cold mixture of 4% paraformaldehyde and 0.05% glutaraldehyde in 0.1 M PB for 1 h. Brainstems were removed and postfixed by immersion in the same fixative for 4 h at 4 °C. Serial coronal sections of 50 μ m thickness were prepared with a vibratome (VT 1000S, Leica), and approximately 18-20 sections, including the LHb region, were collected from each brain.
Kir4.1 was detected by immunogold-silver staining. In brief, sections were blocked with blocking buffer (5% BSA, 5% NGS and 0.05% Triton X-100 in PBS), and then incubated overnight with primary antibodies (rabbit anti-Kir4.1 extracellular peptide; 1:200, Alomone labs) diluted with solution containing 1% BSA, 1% NGS and 0.05% Triton X-100.The secondary antibody was anti-rabbit IgG conjugated to 1.4-nm gold particles (1:100, Nanoprobes) for 4 h. After rinsing, sections were post fixed in 2% glutaraldehyde in PBS for 45 min. Silver enhancement was performed in the dark with HQ Silver Kit (Nanoprobes) for visualization of Kir4.1 immunoreactivity. Before and after the silver enhancement step, sections were rinsed several times with deionized water.
Immunolabelled sections were fixed with 0.5% osmium tetroxide in 0.1 M PB for 1 h, dehydrated in graded ethanol series and then in propylene oxide, and finally flat-embedded in Epon 812 between sheets of plastic. After polymerization, acrylic sheets were then peeled from the polymerized resin, and flat-embedded sections were examined under the light microscope. Three to four sections containing Kir4.1 immunoreactivity in the LHb were selected from each brain, trimmed under a stereomicroscope, and glued onto blank resin stubs. Serial ultrathin sections were cut with an Ultramicrotome (Leica EM UC6, Germany) using a diamond knife (Diatome) and mounted on formvar-coated mesh grids (6-8 sections per grid). They were then counterstained with uranyl acetate and lead citrate, and observed under a JEM-1230 electron microscope (JEOL) equipped with a CCD camera and its application software (832 SC1000). Stereotaxic surgery and virus injection. cLH rats (P50-60) were deeply anaesthetized using 4% pentobarbital. Mice (P50-60 days) were deeply anaesthetized using ketamine (100 mg/kg of body weight) and xylazine (8 mg/kg). Animals were placed on a stereotactic frame (RWD Instruments). A small volume of virus was injected into the LHb bilaterally (for rats LHb: AP, -3.7 mm from bregma; ML, ± 0.7 mm; DV, -4.55 mm from the brain surface; for mice: AP, -1.72 mm from bregma; ML, ± 0.46 mm; DV, -2.62 mm from the brain surface) using a pulled glass capillary with a pressure microinjector (Picospritzer III, Parker) at a slow rate of 0.1 μ l/min. After the injection was completed, the capillary was left for an additional 10 min before it was then slowly withdrawn completely. After surgery, animals were allowed to recover from anaesthesia under a heat pad.
The following vectors were used: AAV-CaMKIIa::eGFP-Cre (AAV2/1-CaMKIIa-HI-eGFP-Cre, 0.2 μ l, bilateral into LHb, University of Pennsylvania vector core), AAV-GFAP::eGFP-Cre (AAV2/5-gfaABC1D-eGFP-Cre, titre: 4.74 × 10 12 v.g./ml, dilution: 1:2, 0.2 μ l, bilateral into LHb, Taitool Bioscience), AAV-GFAP::Kir4.1 (AAV2/5-gfaABC1D-eGFP-Kir4.1, titre: 9.19 × 10 12 v.g./ml, dilution: 1:5, 0.2 μ l, bilateral into LHb, Taitool Bioscience), AAV-GFAP::eGFP (AAV2/5-gfaABC1D-eGFP, titre: 1.61 × 10 13 v.g./ml, dilution: 1:5, 0.2 μ l, bilateral into LHb, University of Massachusetts, Gao Laboratory), AAV-H1::Kir4.1-shRNA (AAV2/5-H1-Kir4.1-shRNA-CAG-eGFP, titre: 3.04 × 10 13 v.g./ml, dilution: 1:10, 0.2 μ l, bilateral into LHb, Taitool Bioscience), AAV-H1::Ctrl-shRNA (AAV2/5-H1-LuciferaseshRNA-CAG-eGFP, titre: 1.46 × 10 13 v.g./ml, dilution: 1:5, 0.2 μ l, bilateral into LHb, Taitool Bioscience), AAV2/5-gfaABC1D-dnKir4.1-2A-eGFP(GYG to AAA) (titre: 4.15 × 10 13 v.g./ml, 0.2 μ l, bilateral into LHb, Taitool Bioscience). All viral vectors were aliquotted and stored at -80 °C until use. Depression model and behaviour assay. LPS-induced depression. The LPSinduced depression model was used as previously described 22 . Wistar male rats Article reSeArcH (3 months) were used for the experiments. LPS (Sigma, L-2880) dissolved in sterile 0.9% saline was intraperitoneally injected into Wistar rats, at a dosage of 0.5 mg/kg. This dosage was used to stimulate a subclinical infection without inducing obvious inflammation and other apparent impairments in animals. Saline or LPS was injected between 09:30 and 10:30 a.m. daily for 7 days. The forced swim test was performed 24 h after the last injection. The habenular tissue was dissected 24 h after the behavioural test for western blotting or electrophysiology experiments.
Learned helplessness test (LHT).
Male juvenile (P30) or adult (P90) cLH rats were tested in a lever-pressing task to evaluate the learned helplessness (LH) phenotype 14 . A cue-light-illuminated lever in the shock chamber was presented, which terminated the shock when rats pressed the lever. Fifteen escapable shocks (0.8 mA) were delivered with a 24-s inter-shock interval. Each shock lasted up to 60 s unless the rat pressed the lever to terminate the shock. Out of the 15 trials, rats that failed to press the lever for more than ten trials were defined as learned helpless (LH), and rats with fewer than five failures were defined as non-learned helpless (NLH). 33 . Water depth was set to prevent animals from touching the bottom with tails or hind limbs. Animal behaviours were videotaped from the side. The immobility time during the last 4 min of the test was counted offline by an observer blinded to the animal treatments. Immobility was defined as time when animals remained floating or motionless with only movements necessary for keeping balance in the water. For rats, an additional pre-test was conducted 24 h before the test, during which rats were individually placed in a cylinder of water under the conditions described above for 15 min. Sucrose preference test (SPT). Animals were single housed and habituated with two bottles of water for 2 days, followed by two bottles of 2% sucrose for 2 days 33 . Animals were then water deprived for 24 h and then exposed to one bottle of 2% sucrose and one bottle of water for 2 h in the dark phase. Bottle positions were switched after 1 h. Total consumption of each fluid was measured and sucrose preference was defined as the average sucrose consumption ratio during the first and second hours. Sucrose consumption ratio was calculated by dividing total consumption of sucrose by total consumption of both water and sucrose. Open field test (OFT). Animals were placed in the centre of an arena (40 cm × 40 cm × 40.5 cm for mice; 100 cm × 100 cm × 40 cm for rats) in a room with dim light for 10 min. A video camera positioned directly above the arena was used to track the movement of each animal (Any-maze, Stoelting). LHb brain slice preparation. Rats (P25-30 or P60-90) and mice (P90) were anaesthetized with isoflurane and 10% chloral hydrate, and then perfused with 20 ml ice-cold ACSF (oxygenated with 95% O 2 + 5% CO 2 ) containing (mM): 125 NaCl, 2.5 KCl, 25 NaHCO 3 , 1.25 NaH 2 PO 4 , 1 MgCl 2 and 25 glucose, with 1 mM pyruvate added. The brain was removed as quickly as possible after decapitation and put into chilled and oxygenated ACSF. Coronal slices containing the habenula (350 μ m and 300 μ m thickness for rats and mice, respectively) were sectioned in cold ACSF with a Leica 2000 vibratome, transferred to ASCF at 32 °C for incubation and recovery for 1 h and then transferred to room temperature. ACSF was continuously gassed with 95% O 2 and 5% CO 2 . Slices were allowed to recover for at least 1 h before recording. In vitro electrophysiological recording. For LHb neuron recordings, currents were measured under whole-cell patch-clamp recordings using pipettes with a typical resistance of 5-6 MΩ filled with internal solution containing (mM) 105 K-gluconate, 30 KCl, 4 Mg-ATP, 0.3 Na-GTP, 0.3 EGTA, 10 HEPES and 10 Na-phosphocreatine, with pH set to 7.35. For the biocytin filling, 5 mg/ml biocytin was added in the internal solution. The external ACSF solution contained (in mM) 125 NaCl, 2.5 KCl, 25 NaHCO 3 , 1.25 NaH 2 PO 4 , 1 MgCl 2 and 25 glucose. Cells were visualized with infrared optics on an upright microscope (BX51WI, Olympus). A MultiClamp 700B amplifier and pCLAMP10 software were used for electrophysiology (Axon Instruments). The series resistance and capacitance were compensated automatically after a stable Gigaseal was formed. Spontaneous neuronal activity was recorded under current-clamp (I = 0 pA) for 60 s consecutively. RMP was determined during the silent period of neuronal spontaneous activity.
Forced swim test (FST)
To test the effects of TTX (1 μ M, Sigma) and BaCl 2 (100 μ M, Sigma) on neuronal RMP and spontaneous activity, baselines were recorded for at least for 3 min. Then the drug was perfused into the medium with the arrival of the drug being precisely indicated with a bubble that was added before the transition from normal ACSF to ACSF with drug. The effect of TTX on the RMP and spontaneous activity of LHb neurons stabilized after a few minutes, whereas the effect of BaCl 2 took more than 10 min to stabilize. We thus analysed the effects of TTX and BaCl 2 at 5 and 15 min after perfusion started, respectively. Astrocytic whole-cell patch-clamp recordings and Kir4.1 current isolation. Astrocytes were distinguished from neurons by their small (5-10 μ m), oval somata and distinct electrophysiological features: a hyperpolarized RMP (− 74 ± 1 mV), a low input resistance R in (47 ± 6 MΩ ), a linear I-V relationship and an absence of action potentials in response to increased injection currents 34, 35 . BaCl 2 (100 μM, Sigma) was applied to isolate Kir4.1 current, which was subtracted from the I-V curve recorded from − 120 mV to 0 mV. Biocytin (Sigma, 5 mg/ml) was dissolved into the patch-clamp pipette solution. After electrophysiological characterization, cells were held for at least 30 min in voltage clamp and constantly injected with a hyperpolarization current (500 ms, 50 pA, 0.5 Hz, 30 min) to allow biocytin filling (performed at 34 °C). Subsequently, slices were fixed overnight in 4% paraformaldehyde at 4 °C. The antibodies used were rabbit anti-NeuN (1:500, Millipore), Alexa Fluor 546 donkey anti-rabbit IgG (1:1,000, Invitrogen) and Cy2-conjugated streptavidin (1:1,000, Jackson ImmunoResearch). Fluorescent image acquisition was performed with a Nikon A1 confocal microscope. Tri-compartment model. A tri-compartment model was constructed including the neuron, the astrocyte and the extracellular space. The model was based on ionic fluxes between these three compartments. Na + and K + voltage-gated channels, and leak channels were recruited into the neuron as dV N /dt = (I app − I K − I Na − I Leak,N )/c N , where V N is the neuronal membrane potential, c N is the neuronal capacitance, I app is an external current applied to the neuron, I Na and I K are the fast Na + and K + currents of the action potentials, respectively, and I Leak,N is responsible for the neuronal resting membrane potential. To trigger an action potential, we applied an external step current of amplitude 5 nA and duration 0.1 ms. Kir4.1 channels on the extracellular and vessel side and leak channels were recruited into the astrocyte as dV A /dt = (− I Kir − I kir_vess − I Leak,A )/c A , where V A is the astrocytic membrane potential, c A is the astrocytic capacitance, I Kir and I kir_vess account for the K + flow on the side of the neuron and vessel, respectively (I Kir is outward during the resting state, and becomes inward when K + equilibrium potential exceeds the astrocytic membrane potential), and I Leak,A is responsible for the astrocytic resting membrane potential.
The dynamics for K + in the three compartments are described by: 
See Supplementary Information (Model Description and Supplementary Table 2) for detailed formulae. Statistical analyses. The required sample sizes were estimated on the basis of our past experience performing similar experiments. Animals were randomly assigned to treatment groups. Analyses were performed blinded to treatment assignments in all behavioural experiments. Statistical analyses were performed using GraphPad Prism software v6. By pre-established criteria, values were excluded from the Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
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Experimental design 1. Sample size
Describe how sample size was determined. Required sample sizes were estimated based on our past experience performing similar experiments.
Data exclusions
Describe any data exclusions. Values were excluded from the analyses if the viral injection sites were out of LHb.
Replication
Describe whether the experimental findings were reliably reproduced.
The experiment for each experiment was successfully repeated for at least two times.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Animals were randomly assigned to treatment groups.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Analysis were performed in a manner blinded to treatment assignments in all behavioral experiments.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
